Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Income from Continuing OperationsIncome towards Parent CompanyInterest & Investment IncomeInterest ExpensesNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRestructuring CostsRevenueSelling, General & AdministrativeShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax RateWages, Salaries and Other
Others
Ratios

Bicycle Therapeutics (BCYC) EBT (2018 - 2025)

Historic EBT for Bicycle Therapeutics (BCYC) over the last 8 years, with Q3 2025 value amounting to -$58.9 million.

  • Bicycle Therapeutics' EBT fell 856.22% to -$58.9 million in Q3 2025 from the same period last year, while for Sep 2025 it was -$258.7 million, marking a year-over-year decrease of 4916.44%. This contributed to the annual value of -$179.6 million for FY2024, which is 184.17% up from last year.
  • Bicycle Therapeutics' EBT amounted to -$58.9 million in Q3 2025, which was down 856.22% from -$79.2 million recorded in Q2 2025.
  • Over the past 5 years, Bicycle Therapeutics' EBT peaked at -$15.1 million during Q3 2021, and registered a low of -$79.2 million during Q2 2025.
  • For the 5-year period, Bicycle Therapeutics' EBT averaged around -$39.4 million, with its median value being -$39.7 million (2023).
  • Per our database at Business Quant, Bicycle Therapeutics' EBT surged by 3217.83% in 2024 and then tumbled by 12978.11% in 2025.
  • Bicycle Therapeutics' EBT (Quarter) stood at -$19.8 million in 2021, then plummeted by 63.39% to -$32.4 million in 2022, then tumbled by 62.04% to -$52.6 million in 2023, then fell by 11.79% to -$58.8 million in 2024, then dropped by 0.25% to -$58.9 million in 2025.
  • Its EBT stands at -$58.9 million for Q3 2025, versus -$79.2 million for Q2 2025 and -$61.8 million for Q1 2025.